LifeVantage (NASDAQ:LFVN) Posts Earnings Results, Hits Expectations

LifeVantage (NASDAQ:LFVN) posted its quarterly earnings data on Tuesday. The company reported $0.15 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.15, Zacks reports. The company had revenue of $47.21 million for the quarter. LifeVantage had a net margin of 1.47% and a return on equity of 27.85%. LifeVantage updated its FY 2025 guidance to 0.700-0.800 EPS.

LifeVantage Stock Performance

LFVN traded down $0.05 during trading on Wednesday, reaching $12.93. 228,284 shares of the stock were exchanged, compared to its average volume of 60,322. The stock’s 50 day moving average price is $10.77 and its two-hundred day moving average price is $8.31. LifeVantage has a twelve month low of $4.20 and a twelve month high of $14.71. The stock has a market cap of $164.22 million, a P/E ratio of 46.18 and a beta of 0.84.

LifeVantage Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 17th. Investors of record on Monday, September 9th were issued a dividend of $0.04 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $0.16 dividend on an annualized basis and a yield of 1.24%. LifeVantage’s payout ratio is 57.14%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.